Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

BioClinica Adds Compass Research

Private equity-backed Bioclinica Inc. expanded its clinical research offerings with the July 2016 acquisition of Compass Research, LLC, a Florida-based clinical research site network that has direct access to a number of specialized populations with neurodegenerative disorders and other diseases found in aging demographics. The acquisition solidifies Bioclinica’s position as a leading global research network, and the only one with investigator sites in the United States, Europe, Latin America and Asia. Compass Research’s state-of-the-art facilities in Orlando have supported more than 1,300 trials and contributed to the FDA approval of more than 80 biopharmaceutical products.... Read More »

Home Health & Hospice M&A Rebounds

There’s nothing sleepy about the Home Health & Hospice sector. Through the end of July 2016, this market has seen 35 transactions, putting this year on track to beat 2015’s total of 51 deals. Eleven of these 35 deals disclosed prices, totaling approximately $610 million spent so far this year. Sixty-percent of 2016’s home health & hospice acquirers have been other home health & hospice companies, with the busiest players being LHC Group (NASDAQ: LHCG) and privately held Jordan Health Services with two and three acquisitions, respectively. Five separate private equity firms announced five acquisitions, and Kindred Healthcare (NYSE: KND) announced four acquisitions in this... Read More »

Recent Health Care Deals, week ending 07.22.2016

AcquirerTargetPrice Celgene CorporationCollaboration on immuno-oncology drugs$225 million Santen Pharmaceutical Co. Ltd.InnFocus Inc. $225 million Zimmer Biomet HoldingsMedtech SA$132.9 million Janssen BiotechLicense to IONIS-JBI1-2.5Rx$10 million Center Management Group, LLCAssisted living community$4.25... Read More »

Royal Philips Expands With Population Health Management

Royal Philips (NYSE: PHG), the leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, has just acquired Georgia-based Wellcentive, Inc., a privately-held provider of  cloud-based population health management and data analytics solutions for physicians and their organizations, for an undisclosed price. Wellcentive’s capabilities include importing, aggregating and analyzing clinical, claims and financial data across healthcare and hospital systems to allow providers to enhance their coordinated care delivery to satisfy new requirements and reimbursement models. Wellcentive’s applications will be assimilated into the Philip’s HealthSuite Cloud. This... Read More »

Kroger Gobbles Up ModernHEALTH

Specialty pharmacy deals are usually few and far between. But this year, we’ve seen six deals announced in the first seven months. The most recent is from Kroger Co. (NYSE: KR), the giant food and consumer goods retailer. Kroger acquired Modern HC Holdings, the parent company of ModernHEALTH, and plans to merge it with its own specialty pharmacy subsidiary, Axium Pharmacy Holdings. Financial terms were not disclosed. Specialty pharmacy ModernHEALTH has been a portfolio company of Altamont Capital Partners since July 2012, and has grown considerably with Altamont’s help. As Modern Healthcare, the company served customers with complex pharmaceutical therapies, including HIV,... Read More »

Managed Care Mega-Deals Not Too Big to Fail

2015 is about to lose even more of its M&A luster, it seems. Some $91 billion is about to disappear from the record-setting spending on healthcare M&A, thanks to the potential unraveling of two managed care mega-mergers. Bloomberg is reporting that the U.S. Department of Justice plans to file lawsuits seeking to halt the mergers of Aetna (NYSE: AET) and Humana (NYSE: HUM) for $37 billion, and Anthem (NYSE: ANTM) with Cigna (NYSE: CI), for $54.2 billion. For healthcare M&A wonks, 2015 set new records in deal volume, with more than 1,500 deals, and deal value, at $397 billion. The dollar total would have been even higher, at $564 billion, if Pfizer (NYSE: PFE) hadn’t walked... Read More »

Ambulance Companies Speed Up Consolidation

2015 was a big year for medical transportation companies to combine, as six transactions were throughout the year. Halfway through 2016, three more deals have been announced. The most recent involves two Texas companies. Allegiance Mobile Health in Georgetown, Texas serves a population of more than 15 million around the state. In July it acquired San Antonio-based Gemini Ambulance Service, which provides local medical transportation services. In June, Air Medical Group Holdings, a portfolio company of KKR & Co., paid an undisclosed amount for California Shock Trauma Air Rescue (CALSTAR), which operated as a not-for-profit organization at the time. CALSTAR served the entire state of... Read More »

June 2016 M&A Results Show Strength

Uncertainty is the hobgoblin of the merger and acquisition markets, and the month of June was a high point (or low point, depending on your perspective) for anxiety in global financial markets. Still, the healthcare deals kept rolling in. Our preliminary total for June 2016 stands at 115 transactions, exactly equal with the same month a year ago. Compared with May’s total of 141 deals, though, June’s total does look as if someone is applying the brakes. It takes 12 months to make a year, though, and one month’s results do not create a trend. The digital health sector turned in the strongest gain compared with June 2015, when only two deals were announced. This June, 22 deals were announced... Read More »

Q2:16 Results Defy Brexit and Other Uncertainties

You’ve seen the headlines: Global mergers and acquisitions slid in the first half of 2016, as did the combined value. The number of middle market deals completed in the second quarter fell to levels not seen since 2009. Buyers are walking away from targets that could be affected by sudden changes in tax regulations. It’s all thanks to Brexit and the U.S. presidential election. Then there’s the healthcare market. Deal volume actually increased compared with the previous quarter in 2016, and the same quarter a year ago. Deal volume for Q2:16 reached 396 announced transactions, up 11% versus Q1:16’s 358 deals, and 15% higher than last year’s 344 deals in the second quarter. For the first half... Read More »